| BYND 1.18 1.72% | LOBO 0.7316 27.77% | ASBP 0.2361 -9.85% | CTNT 0.0442 -19.34% | FCHL 0.2595 15.33% | XRTX 2.84 26.22% | LOCL 2.7298 45.20% | EDBL 1.0245 11.36% | SOWG 0.156 -34.97% | TOVX 0.312 -23.90% | NVTS 16.17 22.50% | POET 10.41 21.19% | RPGL 0.7451 65.61% | SOXS 18.0295 -3.22% | HIMS 30.46 -1.77% | CLIK 3.6999 43.96% | INTC 66.94 1.89% | NVDA 201.5101 -0.27% | TSLL 13.17 -0.90% | PLUG 3.2 -0.62% | TQQQ 58.529 0.77% | BURU 0.2399 19.95% | BIYA 1.1926 37.06% | TZA 4.8901 -2.10% | SOUN 8.435 1.38% | LCID 7.625 12.96% | SLNH 1.4498 3.56% | OPEN 5.755 7.57% | BULL 7.205 2.78% | SOXL 99.08 3.27% | ONDS 11.1115 3.56% | LZMH 0.1181 -23.81% | NOK 10.585 -0.14% | SMR 12.53 -2.03% | SNAP 5.765 -3.92% | BITO 10.4399 -0.19% | SOFI 19.53 0.15% | SQQQ 56.48 -0.76% | PLTR 148.31 1.66% | SPRC 5.6701 34.04% | DVLT 0.7655 3.80% | NFLX 93.6601 -1.23% | FFAI 0.3297 15.00% | TSLA 390.81 -0.43% | AMZN 252.5026 1.70% | ALBT 0.3966 -19.03% | GPUS 0.1594 6.13% | HTZ 7.73 -1.02% | MRVL 153.17 3.61% | GNPX 1.1999 3.89%

LifeMD Inc (NASDAQ:LFMD) Targets Substantial Growth in the Virtual Healthcare Sector

LifeMD Inc (NASDAQ:LFMD) is a key player in the virtual healthcare industry, offering primary care services and pharmacy solutions. The company is recognized for its innovative telehealth platform, which has earned it a spot on the 2025 Deloitte Technology Fast 500™ and TIME's America's Growth Leaders of 2026 lists. These accolades highlight LifeMD's strong revenue growth and financial stability.

On November 24, 2025, Ilya Zubkov from Loop Capital Markets set a price target of $8 for LFMD. At that time, the stock was trading at $3.97, suggesting a potential price increase of about 98.49%. This optimistic outlook reflects the company's robust market position and its ability to capitalize on the growing demand for virtual healthcare services.

LifeMD's stock has shown some volatility, with a recent price range between $3.91 and $4.06. Despite this, the stock has seen a 3.12% increase, with a change of $0.12. Over the past year, LFMD's stock has fluctuated significantly, reaching a high of $15.84 and a low of $3.43, indicating potential for substantial growth.

The company's market capitalization stands at approximately $191.1 million, with a trading volume of 1,106,676 shares. LifeMD's commitment to expanding its offerings in high-growth markets like weight management and mental health positions it well for future success. This strategic focus supports the positive price target set by Loop Capital Markets.

Published on: November 24, 2025